FDA Adverse Event
Injury
Summary report: N
FINELINE II
MDR report key: 3212945
·
Received July 9, 2013
Report
- Report Number
- 2124215-2013-09046
- Event Type
- Injury
- Date Received
- July 9, 2013
- Date of Event
- June 3, 2013
- Report Date
- June 3, 2013
- Manufacturer
- CPI - DEL CARIBE
- Product Code
- NVN
- PMA / PMN Number
- P960004
- Adverse Event
- Yes
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- WI
- Reporter Occupation
- PHYSICIAN
Narratives
Additional Manufacturer Narrative · 1
THE LEAD WAS EXPLANTED AND WILL BE RETURNED FOR ANALYSIS. THIS REPORT WILL BE UDPATED ONCE ANALYSIS HAS BEEN COMPLETED.
Description of Event or Problem · 1
BOSTON SCIENTIFIC RECEIVED INFORMATION THAT THIS RIGHT VENTRICULAR (RV) LEAD EXHIBTED INCREASED PACING THRESHOLDS RESULTING IN A LOSS OF CAPTURE (LOC) WITH ASYSTOLE FOR LESS THAN 2 SECONDS OBSERVED. IT DETERMINED THE LEAD HAD BECOME DISLODGED. THE LEAD WAS EXPLANTED DURING NORMAL DEVICE CHANGE OUT. A NEW LEAD WAS IMPLANTED SUCCESSFULLY. THERE WERE NO ADVERSE PATIENT EFFECTS.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 313671 | FINELINE II | IMPLANTABLE LEAD | NVN | CPI - DEL CARIBE | 4479 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 83 YR | Life Threatening| R | 7122| 4543| H220| N140| 4479| 4135| 0292 |